Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Association between time to stent dysfunction and the anti-tumour effect of systemic chemotherapy following stent placement in patients with pancreaticobiliary cancers and malignant gastric outlet obstruction: a retrospective cohort study

Fig. 2

Kaplan-Meier curve of (a) overall survival and (b) progression-free survival. In the entire cohort, which consisted of 109 patients, median progression-free survival and overall survival rates after duodenal stent placement was 3.2 months (95% confidence interval, 2.4–4.0) and 6.0 months (95% confidence interval, 4.6–7.3), respectively. c Comparison of 26 patients who received combination regimen (solid line) and 21 patients who received a monotherapy regimen (dotted line) as the first-line treatment, median progression-free survival rates were 4.5 months (95% confidence interval, 1.7–7.3) and 2.7 months (95% confidence interval, 1.0–4.4) respectively, with a p-value of 0.075

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us